Showing results (101-110 of 7,591) with videos related to
Sort By:
Pageof 760
Neurochemistry International|May 25, 2010
Tryptophan and serotonin turnover rate in the brain of genetically hyperammonemic miceF Chaouloff, D Laude, E Mignot, et al.Journal of Neuroscience Methods|April 5, 2019
DOSED: A deep learning approach to detect multiple sleep micro-events in EEG signalS Chambon, V Thorey, P J Arnal, et al.Experimental Neurology|August 26, 1998
Development of cataplexy in genetically narcoleptic DobermansJ Riehl, S Nishino, R Cederberg, et al.Proceedings of the National Academy of Sciences of the United States of America|April 1, 1989
Prostaglandin E2 and its methyl ester reduce cataplexy in canine narcolepsyS Nishino, E Mignot, B Fruhstorfer, et al.Journal of Sleep Research|June 1, 1997
Circadian distribution of rest/activity in narcoleptic and control dogs: assessment with ambulatory activity monitoringS Nishino, M Tafti, R Sampathkumaran, et al.Lancet (London, England)|January 1, 2000
Hypocretin (orexin) deficiency in human narcolepsyS Nishino, B Ripley, S Overeem, et al.The Journal of Clinical Investigation|September 1, 1988
Role of central alpha-1 adrenoceptors in canine narcolepsyE Mignot, C Guilleminault, S Bowersox, et al.The Journal of Comparative Neurology|March 10, 1997
Mesopontine organization of cholinergic and catecholaminergic cell groups in the normal and narcoleptic dogM Tafti, S Nishino, W Liao, et al.Sleep|December 1, 1993
Desmethyl metabolites of serotonergic uptake inhibitors are more potent for suppressing canine cataplexy than their parent compoundsS Nishino, J Arrigoni, J Shelton, et al.Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society|July 4, 2001
Narcolepsy: clinical features, new pathophysiologic insights, and future perspectivesS Overeem, E Mignot, J G van Dijk, et al.Pageof 760